APN-NJ (Advanced Practice Nurses of New Jersey)
is a Grassroots advocacy coalition of APNs, nurses and citizens in concert with our state nursing organization who are committed to improving healthcare in the state by removing scope of practice barriers. APNs are a solution to the healthcare access crisis.
Updates
FULL PRACTICE AUTHORITY for APNs in
Primary Care and Behavioral Health
THIS IS SIGNIFICANT PROGRESS (but not perfection)
Pharmacies and Insurance Companies Refusing to Honor APNs Scripts
without a collaborating physician's name on the prescription:
If you run into this problem while the EO#112 waiver is still in place,
please download and send, hand deliver or have your patient bring to the pharmacy the following letter 
while we continue to work on this.
You may also use and share this link NJDCU to stay up to date.
Announcements
Effective Treatments for Opioid Addiction:
Recovery Is Possible!
IMPORTANT!Misinformation is being distributed by NJ Physician Groups to NJ Legislators re: APN practice and FPA.Please READ
Nurse Practitioners and Advanced Practice Nurses of NJ need your support to assure access to care in NJ.
|
Opioid Abuse Prevention
New Jersey is confronting a staggering public health crisis brought about by prescription opioid abuse. On February 15, 2017, P.L. 2017, c. 28, was signed into law, imposing certain restrictions on how opioids and other Schedule II controlled dangerous substances may be prescribed. In response to the new law, the Attorney General and New Jersey's prescribing boards adopted new rules designed to reduce the risk of addiction and the accumulation of opioids in the household medicine cabinets across the State, which are very often diverted for illegal use. Information about those rules, as well as guidance for prescribers and patients on safer pain medication prescribing practices is available here.
FREQUENTLY ASKED QUESTIONS For Advance Practice Nurses Licensed by the Board of Nursing. State law makes it unlawful for a prescriber to issue an initial prescription for acute pain for more than a five-day supply. In addition, the dosage authorized by initial prescriptions for acute pain is to be limited to the lowest effective dose of an immediate–release opioid drug. To better understand how to comply with this limitation and other rule changes, the Board offers the following guidance.
Fin
Find Out MoreRules and regulations of the Division of Consumer Affairs, the boards and committees in, and other units of, the Division are codified in Title 13 of the New Jersey Administrative Code, published by LexisNexis. Notices of proposal and notices of adoption are printed in the New Jersey Register, also published by LexisNexis.
The official text of the rules and regulations and their regulatory history and notices of rule proposals and adoptions can be found through the free LexisNexis Public Access Portal.
|
